Fig. 3From: Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization studyMR conservative analysis results using genetically and biologically prioritized variants as instrumental variables. The genetic instruments we chose were prioritized in the original GWAS on metabolites using two approaches, namely a hypothesis-free genetic approach and a biological knowledge-based approach [20], which suggested likely causal genes for the amino acids. CI, confidence intervals; IV, instrumental variable; MAFLD, metabolic dysfunction-associated fatty liver disease; OR, odds ratio; SD, standard deviationBack to article page